Close Menu

NEW YORK (GenomeWeb) – Bioinformatics startup PierianDx announced today that it has partnered with Cancer Genetics to join their respective technologies into a precision oncology testing and analysis offering.

Under the alliance, the companies will combine Cancer Genetics' Focus::NGS tests — which use next-generation sequencing to provide insights into the genetics underlying solid tumors and hematologic malignancies — with PierianDx's Clinical Genomics WorkSpace software for NGS data management.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.